Sales rise 19.47% to Rs 1362.60 crore
Net profit of Natco Pharma rose 59.05% to Rs 668.50 crore in the quarter ended June 2024 as against Rs 420.30 crore during the previous quarter ended June 2023. Sales rose 19.47% to Rs 1362.60 crore in the quarter ended June 2024 as against Rs 1140.50 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales1362.601140.50 19 OPM %59.0646.30 -PBDT847.70543.50 56 PBT803.60500.00 61 NP668.50420.30 59Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content